http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1353678-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fedf5e91eacd5e03750897c0e66e73e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
filingDate 2002-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8af2f2b8f8fe6078f3e4697809aace83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eedafb6c4265fb2a4db098d36abcc452
publicationDate 2003-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1353678-A2
titleOfInvention Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
abstract Glycerophosphates, particularly calcium glycerophosphate (CGP), have been found to mitigate certain abdominal-area physical problems including irritable bowel syndrome and urinary urgency. It is believed that calcium and glycerophosphate, taken orally, are introduced into the human and other animal system such that the glycerophosphate and/or calcium exert a damping, soothing, irritant-interdictive or antispasmodic action on the intestinal, urinary bladder and other smooth muscle organs. Using glycerophosphates, a method is provided for alleviating, palliating, and reducing the syndromes and conditions of discomfort resulting from a variety of diseases, including irritable bowel syndrome, interstitial cystitis, inflammatory bowel disease, fibromyalgia, urinary urgency, benign prostatic hypertrophy, vulvodynia and external genital pain. It is also suggested that muscular energy supplied via glycolysis, the source of anaerobic energy, may be facilitated by the administration of a glycerophosphate moiety to the body's glycerophosphate shuttle.
priorityDate 2001-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226578066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226547757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226578065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10198924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452223748
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68104723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID754
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3816
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53445139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407563347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408241585
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453022265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 41.